These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36763538)

  • 1. BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia.
    Olesinski EA; Bhatia KS; Mahesh AN; Rosli S; Mohamed JS; Jen WY; Jain N; Garcia JS; Wong GC; Ooi M; Letai A; Konopleva M; Bhatt S
    Blood Adv; 2023 Jun; 7(12):2917-2923. PubMed ID: 36763538
    [No Abstract]   [Full Text] [Related]  

  • 2. Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199.
    Chonghaile TN; Roderick JE; Glenfield C; Ryan J; Sallan SE; Silverman LB; Loh ML; Hunger SP; Wood B; DeAngelo DJ; Stone R; Harris M; Gutierrez A; Kelliher MA; Letai A
    Cancer Discov; 2014 Sep; 4(9):1074-87. PubMed ID: 24994123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia.
    Saygin C; Giordano G; Shimamoto K; Eisfelder B; Thomas-Toth A; Venkataraman G; Ananthanarayanan V; Vincent TL; DuVall A; Patel AA; Chen Y; Tan F; Anthony SP; Chen Y; Shen Y; Odenike O; Teachey DT; Kee BL; LaBelle J; Stock W
    Clin Cancer Res; 2023 Aug; 29(16):3151-3161. PubMed ID: 37363966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia.
    Bodaar K; Yamagata N; Barthe A; Landrigan J; Chonghaile TN; Burns M; Stevenson KE; Devidas M; Loh ML; Hunger SP; Wood B; Silverman LB; Teachey DT; Meijerink JP; Letai A; Gutierrez A
    Leukemia; 2022 Jun; 36(6):1499-1507. PubMed ID: 35411095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia.
    Peirs S; Matthijssens F; Goossens S; Van de Walle I; Ruggero K; de Bock CE; Degryse S; Canté-Barrett K; Briot D; Clappier E; Lammens T; De Moerloose B; Benoit Y; Poppe B; Meijerink JP; Cools J; Soulier J; Rabbitts TH; Taghon T; Speleman F; Van Vlierberghe P
    Blood; 2014 Dec; 124(25):3738-47. PubMed ID: 25301704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SET-CAN fusion gene as poor prognosis predictor in adult T-cell acute lymphoblastic leukemia.
    Yang Q; Qian H; Jin Z; Yu Z; Yu K; Zhang S; Jiang S
    Leuk Lymphoma; 2020 Jan; 61(1):217-220. PubMed ID: 31502502
    [No Abstract]   [Full Text] [Related]  

  • 7. The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest.
    Ben Abdelali R; Asnafi V; Petit A; Micol JB; Callens C; Villarese P; Delabesse E; Reman O; Lepretre S; Cahn JY; Guillerm G; Berthon C; Gardin C; Corront B; Leguay T; Béné MC; Ifrah N; Leverger G; Dombret H; Macintyre E
    Haematologica; 2013 Nov; 98(11):1711-7. PubMed ID: 23831922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V
    Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 maturation pattern in T-cells distinguishes thymic neoplasm/hyperplasia, T-lymphoblastic lymphoma, and reactive lymph nodes.
    Ward N; Baqai J; Zehnpfennig A; Fine N; Huang J; Smith MD
    Cytometry B Clin Cytom; 2018 May; 94(3):444-450. PubMed ID: 28718205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia.
    Kontro M; Kuusanmäki H; Eldfors S; Burmeister T; Andersson EI; Bruserud O; Brümmendorf TH; Edgren H; Gjertsen BT; Itälä-Remes M; Lagström S; Lohi O; Lundán T; Martí JM; Majumder MM; Parsons A; Pemovska T; Rajala H; Vettenranta K; Kallioniemi O; Mustjoki S; Porkka K; Heckman CA
    Leukemia; 2014 Aug; 28(8):1738-42. PubMed ID: 24573384
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signaling.
    Seyfried F; Demir S; Hörl RL; Stirnweiß FU; Ryan J; Scheffold A; Villalobos-Ortiz M; Boldrin E; Zinngrebe J; Enzenmüller S; Jenni S; Tsai YC; Bornhauser B; Fürstberger A; Kraus JM; Kestler HA; Bourquin JP; Stilgenbauer S; Letai A; Debatin KM; Meyer LH
    Cell Death Dis; 2019 Jul; 10(8):571. PubMed ID: 31358732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of miR-16 in patients with T lymphoblastic lymphoma/acute lymphoblastic leukemia].
    Tong LG; Wu WZ; Zhang YP; Zhou ZG; Chen YF; Huang WJ; Xu H; Su QQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):99-103. PubMed ID: 24598659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute lymphoblastic leukemia with T + PH1 monocytosis: a case report].
    Braham Jmili N; Sendi H; Khelif A
    Ann Biol Clin (Paris); 2011; 69(4):473-5. PubMed ID: 21896415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia.
    Del Gaizo Moore V; Schlis KD; Sallan SE; Armstrong SA; Letai A
    Blood; 2008 Feb; 111(4):2300-9. PubMed ID: 18056841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia.
    Lapucci A; Lulli M; Amedei A; Papucci L; Witort E; Di Gesualdo F; Bertolini F; Brewer G; Nicolin A; Bevilacqua A; Schiavone N; Morello D; Donnini M; Capaccioli S
    FASEB J; 2010 Jun; 24(6):1852-65. PubMed ID: 20103721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells.
    Alford SE; Kothari A; Loeff FC; Eichhorn JM; Sakurikar N; Goselink HM; Saylors RL; Jedema I; Falkenburg JH; Chambers TC
    Cancer Res; 2015 Apr; 75(7):1366-75. PubMed ID: 25649768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of cryptic chromosomal rearrangements involving the LMO2 gene in T-cell acute lymphoblastic leukemia.
    Wu L; Xu Y; Wang Q; Ruan C; Drexler HG; Wu D; MacLeod RA; Chen S
    Haematologica; 2015 Jun; 100(6):e233-6. PubMed ID: 25682596
    [No Abstract]   [Full Text] [Related]  

  • 18. First description of the t(10;11)(q22;q23)/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia.
    Ittel A; Jeandidier E; Helias C; Perrusson N; Humbrecht C; Lioure B; Mazurier I; Mayeur-Rousse C; Lavaux A; Thiebault S; Lerintiu F; Gervais C; Mauvieux L
    Haematologica; 2013 Dec; 98(12):e166-8. PubMed ID: 24323992
    [No Abstract]   [Full Text] [Related]  

  • 19. DDX3X-MLLT10 fusion in adults with NOTCH1 positive T-cell acute lymphoblastic leukemia.
    Brandimarte L; La Starza R; Gianfelici V; Barba G; Pierini V; Di Giacomo D; Cools J; Elia L; Vitale A; Luciano L; Bardi A; Chiaretti S; Matteucci C; Specchia G; Mecucci C
    Haematologica; 2014 May; 99(5):64-6. PubMed ID: 24584351
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia.
    Peirs S; Frismantas V; Matthijssens F; Van Loocke W; Pieters T; Vandamme N; Lintermans B; Dobay MP; Berx G; Poppe B; Goossens S; Bornhauser BC; Bourquin JP; Van Vlierberghe P
    Leukemia; 2017 Oct; 31(10):2037-2047. PubMed ID: 28074072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.